Status:
COMPLETED
Comparison of Outcome Parameters in Laser Rhytide Treatment
Lead Sponsor:
Laserklinik Karlsruhe
Conditions:
Skin Aging
Eligibility:
All Genders
40-55 years
Phase:
PHASE4
Brief Summary
We previously published a comparative split-face study which has shown a significant, albeit moderate, effect of ablative fractional laser treatment. While indicating that a single session with fracti...
Eligibility Criteria
Inclusion
- mild to moderate peri-orbital rhytides ('crow's feet') at rest (Class II according to Fitzpatrick)
Exclusion
- unrealistic expectations
- inability to meet follow-up criteria
- Fitzpatrick skin phototype \>III
- coagulation disorders or anti-coagulant treatment
- allergy to lidocaine or tetracaine
- oral isotretinoin within the last 6 months
- any active skin disease within the treatment areas (e.g., psoriasis, cancer, or autoimmune disease)
- synthetic implants in the treatment area
- facial cosmetic procedures affecting the treatment area within the last 6 months
- photosensitizing medications (e.g., tetracycline, gold)
- history of keloid formation
- pregnancy
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT00994474
Start Date
August 1 2008
End Date
March 1 2009
Last Update
October 14 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laserklinik Karlsruhe
Karlsruhe, Germany, D-76133